Scarica l'app Stockscreener
1.08
2.70%
-0.03
Dopo l'orario di chiusura:
1.12
0.04
+3.70%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.11
Aprire:
$1.1
Volume 24 ore:
12,379
Relative Volume:
0.33
Capitalizzazione di mercato:
$12.50M
Reddito:
$996.00K
Utile/perdita netta:
$-6.09M
Rapporto P/E:
-2.0377
EPS:
-0.53
Flusso di cassa netto:
$-9.76M
1 W Prestazione:
-6.10%
1M Prestazione:
-6.90%
6M Prestazione:
-16.92%
1 anno Prestazione:
-35.91%
Intervallo 1D:
$1.0601
$1.1193
Intervallo di 1 settimana:
$1.0601
$1.18
Portata 52W:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Nome
Therapeuticsmd Inc
Settore
Telefono
561-961-1900
Indirizzo
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Confronta TXMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.08 | 13.19M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
155.61 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.31 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.80 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
310.66 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-07 | Downgrade | Jefferies | Hold → Underperform |
| 2020-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Iniziato | Guggenheim | Buy |
| 2019-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-30 | Ripresa | Noble Capital Markets | Outperform |
| 2018-06-15 | Iniziato | JP Morgan | Overweight |
| 2017-09-08 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Ripresa | Jefferies | Buy |
| 2016-11-22 | Iniziato | Oppenheimer | Outperform |
| 2016-11-07 | Ripresa | Guggenheim | Buy |
| 2016-04-04 | Iniziato | Goldman | Buy |
| 2015-12-08 | Reiterato | Jefferies | Buy |
| 2015-12-08 | Reiterato | Stifel | Buy |
| 2015-09-21 | Reiterato | Jefferies | Buy |
| 2015-06-09 | Iniziato | Guggenheim | Buy |
| 2014-07-08 | Iniziato | FBR Capital | Outperform |
| 2014-04-17 | Reiterato | Noble Financial | Buy |
| 2014-01-28 | Reiterato | Noble Financial | Buy |
Mostra tutto
Therapeuticsmd Inc Borsa (TXMD) Ultime notizie
Custom watchlist performance reports with TherapeuticsMD Inc.2025 Geopolitical Influence & Expert-Curated Trade Recommendations - Newser
TherapeuticsMD Swings to Profit in Q2 - Mitrade
What makes TherapeuticsMD Inc. stock price move sharplyJuly 2025 Trade Ideas & AI Based Buy and Sell Signals - Newser
Quantitative breakdown of TherapeuticsMD Inc. recent moveAnalyst Downgrade & Verified Momentum Stock Ideas - Newser
What MACD signals say about TherapeuticsMD Inc.Take Profit & Risk Adjusted Buy and Sell Alerts - Newser
Short interest data insights for TherapeuticsMD Inc.Weekly Trading Summary & Consistent Return Investment Signals - Newser
Analyzing drawdowns of TherapeuticsMD Inc. with statistical toolsJuly 2025 Technicals & Safe Entry Trade Reports - Newser
Has TherapeuticsMD Inc. formed a bullish divergenceWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
Is TherapeuticsMD Inc. meeting your algorithmic filter criteriaQuarterly Trade Summary & Precise Swing Trade Alerts - Newser
Will TherapeuticsMD Inc. continue its uptrendPortfolio Update Report & Weekly Setup with ROI Potential - Newser
Using data tools to time your TherapeuticsMD Inc. exitWeekly Gains Summary & Daily Stock Trend Watchlist - Newser
Published on: 2025-08-19 16:42:31 - Newser
Published on: 2025-08-19 14:42:22 - Newser
What to do if you’re stuck in TherapeuticsMD Inc.2025 Macro Impact & AI Enhanced Trading Alerts - Newser
Tick level data insight on TherapeuticsMD Inc. volatilityJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Will breakout in TherapeuticsMD Inc. lead to full recoveryMarket Activity Summary & Daily Momentum Trading Reports - Newser
What’s the recovery path for long term holders of TherapeuticsMD Inc.2025 Trading Volume Trends & Daily Profit Maximizing Tips - Newser
Signal strength of TherapeuticsMD Inc. stock in tech scannersEarnings Miss & Smart Money Movement Tracker - Newser
Using fundamentals and technicals on TherapeuticsMD Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
TherapeuticsMD Inc. stock trend forecastJuly 2025 Patterns & Risk Controlled Daily Plans - Newser
Leading vs lagging indicators on TherapeuticsMD Inc. performancePortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
Can volume confirm reversal in TherapeuticsMD Inc.July 2025 Closing Moves & Safe Entry Point Identification - Newser
Is it time to cut losses on TherapeuticsMD Inc.2025 Fundamental Recap & Capital Protection Trade Alerts - Newser
How TherapeuticsMD Inc. stock performs during market volatilityJuly 2025 Selloffs & Risk Managed Investment Strategies - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningSell Signal & AI Enhanced Trade Execution Alerts - Newser
Market reaction to TherapeuticsMD Inc.’s recent newsJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
Is TherapeuticsMD Inc. stock ready for a breakoutGap Down & Long-Term Safe Investment Plans - Newser
Therapeuticsmd Inc Azioni (TXMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Therapeuticsmd Inc Azioni (TXMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
| Collins Cooper C. | Director |
Aug 22 '24 |
Buy |
1.73 |
4,094 |
7,099 |
52,016 |
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):